Helping You Build Wealth With Honest Research
Since 1996. Read On...

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

THYROCARE TECHNOLOGIES Gains 7%; BSE HEALTHCARE Index Up 0.2%
Wed, 24 Jul 9:49

THYROCARE TECHNOLOGIES Gains 7%; BSE HEALTHCARE Index Up 0.2%Image source: StarLineArts/www.istockphoto.com

THYROCARE TECHNOLOGIES share price has zoomed 7% and is presently trading at Rs 689.7.

Meanwhile, the BSE HEALTHCARE index is at 38,804.3 (up 0.2%).

Among the top gainers in the BSE HEALTHCARE index today are HIKAL CHEMIC (up 4.8%) and Sanofi India (up 3.1%).

Torrent Pharma (down 3.2%) and DR. LAL PATHLABS (down 1.7%) are among the top losers today.

Over the last one year, THYROCARE TECHNOLOGIES has moved up from Rs 583.5 to Rs 689.7, registering a gain of Rs 106.2 (up 18.2%).

On the other hand, the BSE HEALTHCARE index has moved up from 26,789.0 to 38,804.3, registering a gain of 44.9% during the last 12 months.

The top gainers among the BSE HEALTHCARE index stocks during this same period were GSK Pharma (up 96.3%), Jubilant Pharmova (up 94.5%) and Lupin (up 93.6%).

Must See: These Segments are Witnessing Incredible Growth with Modi's Push

What About the Benchmark Indices?

The BSE Sensex is at 80,197.5 (down 0.3%).

The top losers among the BSE Sensex today are Hindustan Unilever (down 3.0%) and Bajaj Finance (down 2.3%). The most traded stocks in the BSE Sensex are ITC and Tata Steel.

In the meantime, NSE Nifty is at 24,409.1 (down 0.3%). Hindustan Unilever and Tata Consumer Products are among the top losers in NSE NIFTY.

Over the last 12 months, the BSE Sensex has moved up from 66,384.8 to 80,197.5, registering a gain of 13,812.7 points (up 20.8%).

THYROCARE TECHNOLOGIES Financial Update...

THYROCARE TECHNOLOGIES net profit grew 41.9% YoY to Rs 243 million for the quarter ended June 2024, compared to a profit of Rs 171 million a year ago. Net sales rose 16.3% to Rs 1,569 million during the period as against Rs 1,349 million in April-June 2023.

For the year ended March 2023, THYROCARE TECHNOLOGIES reported 63.5% decrease in net profit to Rs 644 million compared to net profit of Rs 1,761 million during FY22. Revenue of the company fell 10.6% to Rs 5,267 million during FY23.

The current Price to earnings ratio of THYROCARE TECHNOLOGIES, based on rolling 12 month earnings, stands at 47.9.


Equitymaster requests your view! Post a comment on "THYROCARE TECHNOLOGIES Gains 7%; BSE HEALTHCARE Index Up 0.2%". Click here!